Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects - Liu, Xiaofen; Chen, Yuancheng; Yang, Haijing; Li, Jian; Yu, Jicheng; Yu, Zhenwei; Cao, Guoying; Wu, Xiaojie; Wang, Yu; Wu, Hailan; Fan, Yaxin; Wang, Jingjing; et al. (The Journal of infection, 2021)
Keywords: Administration, Intravenous; Anti-Bacterial Agents - adverse effects; China; Female; Healthy Volunteers; Humans; Male; Neurotoxicity; Pharmacokinetics; Polymyxin; Polymyxin B - adverse effects; Safety; Urinary recovery; China; Neurotoxicity; Safety; Polymyxin; Pharmacokinetics; Urinary recovery